Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Novo Nordisk |
---|---|
Information provided by: | Novo Nordisk |
ClinicalTrials.gov Identifier: | NCT00071448 |
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Pediatric Population
Condition | Intervention | Phase |
---|---|---|
Diabetes Mellitus, Insulin-Dependent |
Drug: human insulin Drug: insulin lispro Drug: insulin aspart |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Bio-equivalence Study |
Ages Eligible for Study: | 6 Years to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Responsible Party: | Novo Nordisk A/S ( Public Access to Clinical Trials ) |
Study ID Numbers: | ANA-2126 |
Study First Received: | October 23, 2003 |
Last Updated: | November 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00071448 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Pediatric, diabetes Diabetes Mellitus |
Metabolic Diseases Autoimmune Diseases Diabetes Mellitus Endocrine System Diseases Insulin LISPRO Diabetes Mellitus Type 1 Insulin |
Hypoglycemic Agents Diabetes Mellitus, Type 1 Insulin, Asp(B28)- Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Metabolic Diseases Autoimmune Diseases Immune System Diseases Physiological Effects of Drugs Diabetes Mellitus Endocrine System Diseases Insulin LISPRO |
Insulin Pharmacologic Actions Hypoglycemic Agents Diabetes Mellitus, Type 1 Insulin, Asp(B28)- Glucose Metabolism Disorders |